The US Food and Drug Administration (FDA) has convened a panel to discuss the use of a common antidepressant during pregnancy.Selective serotonin reuptake inhibitors (SSRIs) are widely used to treat depression and other mental health conditions.Experts are concerned the panel has cast undue doubt on the medication, and changes shouldn’t be made without evidence.Guest/sDr Carolyn Breadon, perinatal psychiatrist at Alfred HealthReferencesPaternal Depression as a Risk Factor for Neurodevelopmental Disorders in Offspring: Implications for Maternal Depression and Its Treatment During PregnancyAssociation Between Serotonergic Antidepressant Use During Pregnancy and Autism Spectrum Disorder in Children

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related